This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
Ketamine for mood disorders. Lansdale: HAYES, Inc.. Directory Publication. 2012
Intravenous injection of ketamine hydrochloride is intended to reduce symptoms of depression in patients with treatment-resistant depression.
Subject indexing assigned by CRD
Humans; Ketamine; Mood Disorders
Country of organisation
An English language summary is available.
Address for correspondence
HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: firstname.lastname@example.org
Date abstract record published